Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1999
12/16/1999CA2319730A1 Bradykinin antagonists
12/16/1999CA2319651A1 H1-histamine receptor antagonists
12/16/1999CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999CA2319495A1 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999CA2319477A1 Inhibitors of h+k+-atpase
12/16/1999CA2319474A1 Inhibitors of nitric oxide synthase
12/16/1999CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999CA2319174A1 Novel therapeutic agents that modulate 5-ht receptors
12/16/1999CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999CA2319120A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999CA2318901A1 Novel calcium channel drugs and uses
12/16/1999CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2318745A1 Novel potassium channel drugs and their uses
12/16/1999CA2318547A1 Combinatorial synthesis of multibinding libraries
12/16/1999CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999CA2318055A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2316999A1 Inhibitors of hiv reverse transcriptase
12/16/1999CA2316994A1 Composition and method for prevention and treatment of cardiopulmonary and renal failure or damage associated with ischemia, endotoxin release, ards or brought about by administration of certain drugs
12/16/1999CA2315883A1 Muscarinic receptor antagonists
12/16/1999CA2300082A1 Fixation inhibitors for helicobacter pylori
12/16/1999CA2299678A1 Tgf.beta. rii receptor nucleic sequence, coded peptide, and uses
12/15/1999EP0963998A1 Compositions for treating or preventing prostatic cancer
12/15/1999EP0963988A2 Method of making camptothecin and camptothecin analogs
12/15/1999EP0963987A2 Spiro(piperidine-4,1'-pyrrolo(3,4-c)pyrrole)
12/15/1999EP0963986A2 5,10-Dihydrodipyrido(2,3-b:2,3-e)pyrazine and 5,10-dihydro(2,3-b:3,2-e)pyrazine, process for their preparation and pharmaceutical compositions containing them
12/15/1999EP0963985A2 Di-or triaza-spiro(4,5)decane derivatives
12/15/1999EP0963984A1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
12/15/1999EP0963983A1 Indol-2-ones as serotonin modulators
12/15/1999EP0963981A1 Biaryl heterocyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
12/15/1999EP0963980A2 1,2,4-Triazine derivative, its preparation and its use as reference marker for testing purity and stability of "lamotrigine"
12/15/1999EP0963757A2 Hemostatic agent
12/15/1999EP0963756A2 Inhibition of LDL oxidation and atherosclerosis
12/15/1999EP0963755A2 Use of benzopyranes for preventing allograft rejection
12/15/1999EP0963754A1 Cosmetic or dermatologic composition containing carnitine and/or an acylcarnitine and at least a retinoid
12/15/1999EP0963441A1 Inactivation of hiv co-receptors as therapy for hiv infection
12/15/1999EP0963440A1 Improved methods for transducing cells
12/15/1999EP0963431A1 NOVEL FabH
12/15/1999EP0963372A1 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists
12/15/1999EP0963371A1 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
12/15/1999EP0963370A1 Integrin antagonists
12/15/1999EP0963219A1 Manipulations of nitrosative and oxidatives stress in the treatment of disease
12/15/1999EP0963203A2 Mammalian tolloid-like gene and protein
12/15/1999EP0963202A1 Formulations and methods for providing prolonged local anesthesia
12/15/1999EP0963201A1 Transdermal application of naturally occurring steriod hormones
12/15/1999EP0963200A2 Methods and compositions for inhibition of angiogenesis
12/15/1999EP0963199A1 Treatment of disease states which result from neoplastic cell proliferation using ppar-gamma activators and compositions useful therefor
12/15/1999EP0963198A1 ANTI-PARASITIC ACTION OF N,N-DIETHYL-m-TOLUAMIDE (DEET) AND FORMULATIONS THAT PROLONG ITS ACTIVITY IN THE SKIN
12/15/1999EP0963197A1 Guanylhydrazones useful for treating diseases associated with t cell activation
12/15/1999EP0963195A1 Compositions containing an antifungal and a cationic agent
12/15/1999EP0806894A4 Micellar nanoparticles
12/15/1999EP0805806B1 Method for preparing 4,10-diacetoxy-2alfa-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxo-tax-11-en-13alfa-yl (2r,3s)-3-benzoylamino-2-hydroxy-3-phenylpropionate trihydrate
12/15/1999EP0788366B1 Use of 2'-substituted oligonucleotides to down-regulating gene expression
12/15/1999EP0765305B1 Anti-inflammatory compounds
12/15/1999EP0750612B1 Acridone-derived bisintercalators as chemotherapeutic agents
12/15/1999EP0749434B1 Benzothiophene, benzofuran and indolethiazepinones, oxazepinones and diazepinones as inhibitors of cell adhesion and as inhibitors of hiv
12/15/1999EP0743949B1 Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy
12/15/1999EP0725782B1 A 1 adenosine receptor agonists and antiagonists
12/15/1999EP0685457B1 Glycerol derivative, device and pharmaceutical composition
12/15/1999EP0664703B1 Methods of combating (pneumocystis carinii) pneumonia and compounds useful therefor
12/15/1999EP0658110B1 Use of norastemizole for the treatment of allergic rhinitis
12/15/1999EP0646008B1 Minimizing progestin associated breakthrough bleeding
12/15/1999EP0642504B1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
12/15/1999EP0638079B1 Deazaaminopterins for treatment of inflammation
12/15/1999EP0631505B1 Use of a peptide
12/15/1999EP0610439B1 Pyrimidocycloalkanes as angiotensin ii antagonists
12/15/1999EP0529008B1 Modulation of gene expression through interference with rna secondary structure
12/15/1999CN1238807A Stabilized transient gene expression
12/15/1999CN1238789A Water-soluble polymers for reduction of dietary phosphate or oxalate absorption
12/15/1999CN1238783A Method and novel compounds for use therein
12/15/1999CN1238779A Method and compounds for inhibiting 'beta'-amyloid peptide release and/or synthesis
12/15/1999CN1238776A Process for the preparation of salts and esters of clavulanic acid
12/15/1999CN1238775A Cephalosporin derivatives
12/15/1999CN1238773A Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
12/15/1999CN1238772A Novel phenanethridinium derivatives
12/15/1999CN1238771A 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
12/15/1999CN1238770A Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
12/15/1999CN1238766A 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
12/15/1999CN1238765A N-(imidazoly (butyl) benzenesulphonamide derivatives with anticoagulation active
12/15/1999CN1238764A ApoB-secretion/MTP inhibitory amides
12/15/1999CN1238762A Piperidine compounds
12/15/1999CN1238761A Benzamidoaldehydes and their use as cryteine protease inhibitors
12/15/1999CN1238760A N-(aryl/heteroaryl/alkyl acetyl) amino acid esters, pharmaceutical composition comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
12/15/1999CN1238759A Nitrone derivatives
12/15/1999CN1238756A Asiatic acid dervatives and medicines for treating wounds, which contains the same
12/15/1999CN1238755A Asiatic acid derivatives having modified A-ring
12/15/1999CN1238700A Improvents in or relating to diagnostic/therapeutic agents
12/15/1999CN1238697A Use of melanoma differentiation associated gene (mda 7) for reversing cancerous phenotype
12/15/1999CN1238693A Pharmaceutical composition comprising compound having anti-Xa activity and platelet aggregation antagonist compound
12/15/1999CN1238692A Medicines for treating detentia or congitive disorder which comprises asiatic acid derivatives
12/15/1999CN1238691A Liquid alendronate preparation
12/15/1999CN1238690A Improved pharmaceutical compositions
12/15/1999CN1238689A Vitronectin receptor antagonists
12/15/1999CN1238688A Thiol sulfonamide metalloprotease inhibitors
12/15/1999CN1238687A An oil composition of dihydropolyprenols
12/15/1999CN1238454A Compound and its use
12/15/1999CN1238215A Agent having untitumor activity
12/15/1999CN1238212A Liquid medicine for treating disseases of eye, ear, nose and throat
1 ... 6395 6396 6397 6398 6399 6400 6401 6402 6403 6404 6405 6406 6407 6408 6409 6410 6411 6412 6413 6414 6415 ... 7860